Your browser doesn't support javascript.
loading
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations.
Boquoi, Amelie; Rings, Veronika; Mohring, Annemarie; Savickaite, Ingrida; Zukovs, Romans; Strapatsas, Judith; Nachtkamp, Kathrin; Kobbe, Guido; Germing, Ulrich; Fenk, Roland.
Afiliação
  • Boquoi A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Rings V; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Mohring A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Savickaite I; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Zukovs R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Strapatsas J; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Nachtkamp K; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
  • Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Heinrich Heine University, 40225 Duesseldorf, Germany.
Cancers (Basel) ; 14(9)2022 Apr 26.
Article em En | MEDLINE | ID: mdl-35565276
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2022 Tipo de documento: Article